实施远程医疗计划对被诊断患有喘的患者的影响
Héctor Cabrerizo-Carreño1,2,3, Mariana Muñoz-Esquerre4,5,6, Salud Santos Pérez1,3,7
1Bellvitge University Hospital, Department of Pulmonary Medicine, L'Hospitalet de Llobregat, Catalunya, ES, Spain.
BMC pulmonary medicine
|January 12, 2024
概括
一个移动应用程序 (ESTOI) 在临床试验中改善了喘控制和生活质量. 这种工具可以提高患者的监测和严重喘病例的治疗坚持.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 数字健康数字健康
- 临床试验 临床试验
背景情况:
- 喘是全球普遍存在的呼吸系统疾病.
- 尽管取得了进展,但50%的严重喘病例经历过不充分的监测.
- 这凸显了改善患者管理策略的迫切需要.
研究的目的:
- 评估ESTOI移动应用程序在喘管理中的有效性.
- 评估应用程序对患者遵守治疗和感知生活质量的影响.
- 为了确定数字工具是否可以增强严重病例的喘护理.
主要方法:
- 这是一项为期52周的随机临床试验,涉及西班牙108名喘患者.
- 干预小组使用ESTOI应用程序进行症状控制,建议和医疗聊天.
- 关键的评估包括喘控制测试 (ACT),吸入器坚持和螺旋计.
主要成果:
- 通过ESTOI应用程序干预,喘控制显著改善.
- 使用该应用程序的患者表现出更好地遵守治疗方案.
- 移动应用程序对生活质量得分产生了积极的影响.
结论:
- ESTOI移动应用程序是加强喘管理的有效工具.
- 数字健康干预措施可以显著改善患者的监测和遵守.
- 实施这些应用程序有望在严重喘患者中获得更好的结果.
相关概念视频
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
299
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
299
Antiasthma Drugs: β2-Adrenoceptor Agonists
267
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
267


